On Jul. 8, 2020, the United States Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) announced the initial purchase of vaccine for the National Animal Vaccine and Veterinary Countermeasures Bank (NAVVCB). APHIS will invest $27.1 million in foot-and-mouth disease vaccine, which the Agency would use in the event of an outbreak to protect animals and help stop the spread of disease. 

Vaccination helps control the spread of infection by reducing the amount of virus shed by animals and by controlling clinical signs of illness. While an outbreak would temporarily disrupt international markets, vaccination would allow animals to move through domestic production channels. Foot-and-mouth disease is not a threat to public health or food safety.  It is also not related to hand, foot, and mouth disease, which is a common childhood illness caused by a different virus.

The NAVVCB is one component of a three-part program established by the 2018 Farm Bill to comprehensively support animal disease prevention and management. The new U.S.-only vaccine bank—a concept APHIS officials have long discussed with stakeholders and industry—makes a much larger number of vaccine doses available than we currently have through the North American Foot and Mouth Disease Vaccine Bank.  APHIS will continue to participate in the North American Foot and Mouth Disease Vaccine Bank, and this new program adds to the nation’s level of protection against this devastating disease. In the event of an outbreak, animal health officials would decide when, where and how to use the available vaccine, based on the circumstances of the outbreak.